No Picture
News

National Cancer Center Japan Launches Multi-Center Randomized Trial Using Signatera(TM) MRD Testing in Stage II-III Colorectal Cancer

Pivotal Study of 1500 Patients Could Lead to Change in Practice Guidelines

SAN CARLOS, Calif., Jan. 15, 2020 /PRNewswire/ — Today Natera, Inc. (NASDAQ: NTRA) announced an agreement with the National Cancer Center (NCC) Japan to launch the CIRCULATE-… […]

No Picture
News

Quantum Leap Healthcare Collaborative and G1 Therapeutics Announce the Selection of Trilaciclib in the I-SPY 2 TRIAL for Breast Cancer

SAN FRANCISCO and RESEARCH TRIANGLE PARK, N.C., Jan. 14, 2020 /PRNewswire/ — Quantum Leap Healthcare Collaborative™ and G1 Therapeutics, Inc. (Nasdaq: GTHX) announced today a collaboration to evaluate trilaciclib, an investigational therapy designe… […]

No Picture
News

Earlens Announces Partnership with Verily to Develop Next-Generation Capabilities for Earlens® Contact Hearing Solution

MENLO PARK, Calif., Jan. 13, 2020 /PRNewswire/ — Earlens Corporation, a medical technology company that has created the world’s first nonsurgical hearing solution that directly vibrates the eardrum, announced today that they have entered into a str… […]

No Picture
News

Kyverna Therapeutics Secures $25 Million Series A Funding from Key Investors and Enters into Strategic Collaboration with Gilead Sciences

Collaboration Brings Together Gilead’s Commitment to Advancing Cell Therapy with Kyverna’s Focus on Advanced T Cell Engineering Targeting Autoimmune DiseasesSeries A Investors Include Vida Ventures, Westlake Village BioPartners and Gilead SciencesDomin… […]

No Picture
News

Behind the Seizure® Program Further Expands Access to Genetic Testing for Children to Speed the Diagnosis of Genetic Epilepsy

— Biogen, Encoded Therapeutics, Neurogene, Praxis Precision Medicines and PTC Therapeutics join founders BioMarin and Invitae to expand access for children under eight —- Innovative program may shorten the diagnostic odyssey for children who experie… […]

No Picture
News

Berkeley Lights Makes Debut in Korea as Samsung Biologics Adopts the Beacon® Optofluidic Platform for Cell Line Development

EMERYVILLE, Calif. and INCHEON, South Korea, Nov. 26, 2019 /PRNewswire/ — Berkeley Lights, a company dedicated to finding the best cells, continues to see accelerated adoption of the Beacon® optofluidic platform in Asia Pacific as Samsung Biologic… […]